About Diasure Bio
Diasure Bio is a company based in Seoul (South Korea) founded in 2022. Diasure Bio has raised $71.47 thousand across 1 funding round from investors including InfoBank. Diasure Bio offers products and services including Electrochemical BioSensor and 3D Printing Technology. Diasure Bio operates in a competitive market with competitors including Access Bio, SD Biosensor, Lumos Diagnostics, Fluxergy and Module Innovations, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name (주)다이아슈어바이오
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$71.47 K (USD)
in 1 rounds
-
Latest Funding Round
$71.47 K (USD), Seed
Nov 27, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Diasure Bio
Diasure Bio offers a comprehensive portfolio of products and services, including Electrochemical BioSensor and 3D Printing Technology.
Device for detecting biological signals in early disease diagnosis.
System for creating medical prototypes using advanced printing methods.
Funding Insights of Diasure Bio
Diasure Bio has successfully raised a total of $71.47K through 1 strategic funding round. The most recent funding activity was a Seed round of $71.47 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Diasure Bio
Diasure Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include InfoBank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
IT service suite solutions are provided for various business needs.
|
Locked | Locked | Locked |
Investor details for Diasure Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Diasure Bio
Investment portfolio details for Diasure Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Diasure Bio
Detailed financials for Diasure Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Diasure Bio Comparisons
Peer comparison for Diasure Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Diasure Bio
Diasure Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Access Bio, SD Biosensor, Lumos Diagnostics, Fluxergy and Module Innovations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In vitro rapid diagnostic tests, biosensor, and molecular diagnostic products for diagnosis of infectious diseases.
|
|
| Locked | Locked | Locked |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| Locked | Locked | Locked |
Diversified diagnostic assays and readers are developed for point-of-care use.
|
|
| Locked | Locked | Locked |
Provides diagnostic devices and software for clinical and veterinary point-of-care testing.
|
|
| Locked | Locked | Locked |
Diagnostics strip for bacterial detection
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic products for diabetes and tuberculosis are provided.
|
Detailed competitors of Diasure Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Diasure Bio
Complete news archive for Diasure Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diasure Bio
Diasure Bio was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Diasure Bio is headquartered in Seoul, South Korea.
Seunghwa Lee is the current CEO of Diasure Bio.
Diasure Bio is a funded company, having raised a total of $71.47K across 1 funding round to date.
Diasure Bio was founded in 2022 and is based in Seoul, South Korea. Operations focus on the diagnostics sector, where point-of-care testing platforms are provided. Analysis methods and products for diagnosing infectious and genetic diseases are developed using 3D printing technology. The company targets rapid antigen testing solutions to support medical diagnostics in various settings.
Diasure Bio's top competitors include Access Bio, SD Biosensor and Lumos Diagnostics.
Diasure Bio offers Electrochemical BioSensor and 3D Printing Technology.
Diasure Bio has 1 investor. Key investors include InfoBank.